back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-08-02 12:30 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$26,720
+66,800 vol $0.40 each |
66,800 | |
| Filed 2019-08-02 12:27 Tx date 2017-05-10 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-02 12:15 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$20,040
+66,800 vol $0.30 each |
141,800 | |
| Filed 2019-03-06 Tx date 2019-02-08 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$206,999
+300,000 vol $0.69 each |
500,000 | |
| Filed 2019-03-06 Tx date 2018-02-08 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$206,999
+300,000 vol $0.69 each |
||
| Filed 2019-02-15 Tx date 2018-02-08 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$206,999
+300,000 vol $0.69 each |
500,000 | |
| Filed 2019-02-07 Tx date 2019-02-07 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,800
+20,000 vol $0.79 each |
75,000 | |
| Filed 2018-12-20 Tx date 2018-12-19 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,350
+35,000 vol $0.81 each |
55,000 | |
| Filed 2017-12-04 Tx date 2017-05-10 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2017-08-02 Tx date 2017-07-27 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+20,000 vol $0.75 each |
20,000 | |
| Filed 2017-08-02 Tx date 2017-05-10 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-28 Tx date 2016-01-19 |
$IGX
IntelGenx Technologies Corp. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-28 Tx date 2016-01-19 |
$IGX
IntelGenx Technologies Corp. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
| Filed 2016-01-28 Tx date 2016-01-22 |
$IGX
IntelGenx Technologies Corp. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,240
+4,500 vol $0.72 each |
4,500 | |
| Filed 2016-01-28 Tx date 2016-01-19 |
$IGX
IntelGenx Technologies Corp. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-28 Tx date 2016-01-22 |
$IGX
IntelGenx Technologies Corp. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,130
+3,000 vol $0.71 each |
7,500 | |
| Filed 2016-01-28 Tx date 2016-01-22 |
$IGX
IntelGenx Technologies Corp. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,675
+2,500 vol $0.67 each |
10,000 |